ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1117

Prediction Model for Progression to Different Find-Grained MRI-Based Osteoarthritis Severity States: The Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO)

Jolanda Cibere1, Ali Guermazi2, Savvas Nicolaou3, Jacek Kopec4, John Esdaile5, Hubert Wong6, Joel Singer6, Anona Thorne6 and Eric Sayre7, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2Boston University School of Medicine, Boston, MA, 3University of British Columbia, Vancouver, BC, Canada, 4University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada, 5Arthritis Research Canada, Vancouver, BC, Canada, 6University of British Columbia, Vancouver, Canada, 7Arthritis Research Canada, Richmond, BC, Canada

Meeting: ACR Convergence 2020

Keywords: Cohort Study, Magnetic resonance imaging (MRI), Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To develop a novel, fine-grained MRI osteoarthritis (OA) severity score, based on cartilage, osteophytes and meniscus (OA-COM) scores and to predict the progression to different OA severity states using OA-COM scores as the outcome and clinical variables as predictors in a population-based 7-year longitudinal cohort study.

Methods: A population-based cohort, age 40-79, was assessed at baseline, 3- and 7-year follow-up using clinical assessments, x-ray and MRI. MRI OA severity score was based on the sum of scores for cartilage, osteophytes and menisci, measured semi-quantitatively at 6, 8 and 6 sites, respectively, using 0-3 grading for cartilage and osteophytes and 0-2 grading for menisci, for a total score ranging from 0-54, where 0 = no MRI OA and 54 = severe MRI OA. In order to anchor the OA-COM score at interpretable points representing different levels of disease severity, we fit logistic regression models using baseline OA-COM score to predict each baseline Kellgren Lawrence (KL) grade in a subset of data including only KL grades at or one point below the predicted grade. For each model, we produced ROC curves and for each cut point we computed sensitivity, specificity, positive and negative predictive values and sum of squares (SS) of those statistics. The optimal threshold for OA-COM scores in predicting a given KL grade was selected using the cut points with the highest SS, adjusted to attain equal spacing between cut points. To predict progression to different OA severity states, we developed logistic regression models for progression at or above the given OA-COM score cut point from baseline to 7-year follow-up, using the subset of data of patients who could progress; that is, with OA-COM score below the given cut point at baseline. Predictors in multivariable models were selected using forward selection based on best AIC at each step. In order to obtain results that were population-representative, sample weights were used for all analyses.

Results: Of 122 subjects, at baseline, 39.6% had radiographic OA (KL grade ≥2), mean age 55.5, female sex 55.7%. OA-COM score cut points were 12, 18, 24 and 30 for KL grades 1 to 4, respectively. Clinical predictor variables and odds ratios for each OA-COM cut point are shown in the Table 1. BMI was predictive of progression to all OA-COM scores over 7 years. Effusion was a strong predictor for progression to an OA-COM score of 12, 18 and 24, while malalignment and coarse crepitus predicted progression to higher OA-COM scores of 24 and 30.

Conclusion: We have developed a novel MRI OA severity score, the OA-COM score, using cartilage, osteophytes and menisci. OA-COM scores of 12, 18, 24 and 30 represent an MRI score that is equivalent to KL grades 1 to 4, while offering fine-grain differentiation of OA states between KL grades. In prediction modeling, we found that effusion, malalignment and crepitus, as well as age, sex and BMI, were predictive of progression to different states of OA severity over 7 years in this population-based cohort.

Logistic regression analysis to predict progression to OA-COM states, using cut-points 12, 18, 24 and 30 as outcomes.


Disclosure: J. Cibere, None; A. Guermazi, AstraZeneca, 1, Pfizer, 1, MerckSerono, 1, Galapagos, 1, Roche, 1, TissueGene, 1, Boston Imaging Core Lab, 1; S. Nicolaou, None; J. Kopec, None; J. Esdaile, None; H. Wong, None; J. Singer, None; A. Thorne, None; E. Sayre, None.

To cite this abstract in AMA style:

Cibere J, Guermazi A, Nicolaou S, Kopec J, Esdaile J, Wong H, Singer J, Thorne A, Sayre E. Prediction Model for Progression to Different Find-Grained MRI-Based Osteoarthritis Severity States: The Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/prediction-model-for-progression-to-different-find-grained-mri-based-osteoarthritis-severity-states-the-vancouver-longitudinal-study-of-early-knee-osteoarthritis-valseko/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prediction-model-for-progression-to-different-find-grained-mri-based-osteoarthritis-severity-states-the-vancouver-longitudinal-study-of-early-knee-osteoarthritis-valseko/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology